Collegium Pharmaceutical, Inc. COLL EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s EPS (diluted)?
- Collegium Pharmaceutical, Inc. (COLL) reported EPS (diluted) of $0.40 in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s EPS (diluted) changed year-over-year?
- Collegium Pharmaceutical, Inc.'s EPS (diluted) increased by 471.4% year-over-year, from $0.07 to $0.40.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s EPS (diluted) has grown at a 0.3% compound annual growth rate (CAGR), from $1.69 to $1.71.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.